Tus kws kho mob
QP104-20 Update: Cotiviti to Perform Focused and Limited Hospital Bill Validation (HBV) Services
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 28, 2020
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1321 - 1330 ntawm 4179
Tus kws kho mob
QP99-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Insulin Pump PA with QL
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 14, 2020
Tus kws kho mob
QP96-20 Medical Drug Update for New to Market Inclisiran
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 14, 2020
Tus kws kho mob
QP97-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Hemophilia Factor VIII PA with QL
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 14, 2020
Tus kws kho mob
QP98-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Fintepla® (fenfluramine) PA with QL
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 14, 2020
Tus kws kho mob
QP101-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) Criteria: Dojolvi™ PA
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 14, 2020
Tus kws kho mob
QP100-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Hemophilia Factor IX PA with QL
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 14, 2020
Tus kws kho mob
QP95-20 Commercial Pharmacy Benefit Exclusion for Jelmyto®
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 14, 2020
Tus kws kho mob
QP94-20 Commercial Pharmacy Benefit Exclusion for Condylox®, Lyumjev™, Veregen® and Zilxi™
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 14, 2020
Tus kws kho mob
QP102-20 Introducing eviCore’s new intelliPath® Technology
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 14, 2020